Journal
TRENDS IN BIOCHEMICAL SCIENCES
Volume 45, Issue 4, Pages 332-346Publisher
CELL PRESS
DOI: 10.1016/j.tibs.2019.12.008
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [NCI/5 R01 CA223674-02]
Ask authors/readers for more resources
Miniproteins are a diverse group of protein scaffolds characterized by small (1-10 kDa) size, stability, and versatility in drug-like roles. Coming largely from native sources, they have been widely adopted into drug development pipelines. While their structures and capabilities are diverse, the approaches to their utilization share more similarities with each other than with more widely used modalities (e.g., antibodies or small molecules). In this review, we highlight recent advances in miniprotein-based approaches to otherwise poorly addressed clinical needs, including structure-based and functional characterization. We also summarize their unique screening strategies and pharmacology considerations. Through a greater understanding of the unique properties that make them attractive for drug design, miniproteins can be effectively utilized against targets that are intractable by other approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available